Fremanezumab to prevent period-related migraines
Treatments studied
Part of Brain & nervous system, Women’s health & pregnancy clinical trials.
This study tests whether the migraine prevention drug fremanezumab can reduce the number of migraines you get around your period. It is for women who have regular cycles and migraines that are clearly linked to their menstrual period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older who has not gone through menopause and has a regular menstrual cycle (21–32 days).
- You have been diagnosed with migraine (with or without aura) for at least a year and have at least 8 migraine days per month on average for the last 3 months.
- You experience at least 2 days of migraine related to your period per cycle, averaged over the last 3 months.
- You are willing to keep a daily headache diary for the entire study.
- You are not currently taking any other anti-CGRP migraine medication (like Aimovig, Emgality, or Ajovy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the medicine rimegepant can help prevent migraines that happen around your period. It is for women with regular menstrual cycles who have a history of menstrual migraines.
This trial looks at the chemical changes in the blood of people with migraine. It aims to better understand the disease and may help find new treatments. You may qualify if you have episodic or chronic migraine and have not tried CGRP-targeting drugs.
This trial investigates whether a medication usually used for migraines (fremanezumab) can help prevent acute mountain sickness in healthy adults who travel to high altitudes. You would receive an injection and be monitored for symptoms.
This study looks at how preventive treatments (botulinum toxin type A or anti-CGRP antibodies) affect thinking, memory, and quality of life in adults with hard-to-treat migraines. It aims to see if these treatments help more than just reducing headache days.
This trial tests if fremanezumab, a migraine prevention drug, can also reduce the stress and improve the relationship between migraine patients with mild depression and their caregivers. If you or someone you care for has migraines and low mood, this study may help understand how the caregiver is affected.
This study tests whether acupuncture can reduce the number of migraine headaches around your period. If you often get migraines with your menstrual cycle, this treatment might help prevent them.
Hear when a new Menstrual Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.